AMS’s core competence is providing our clients with a tool that allows them to make sense of diverse,

uncertain and complex high-volume markets.

We achieve this by working very diligently at acquiring data through:

• Randomized scientific sampling.

• Projections based on statistically proven formulas.

• Application of Stringent Data Validation methods.

• Continuous update and assessment of our methodology.

AMS issues quarterly sales monitors for the pharmaceutical markets in:

• Iraq since 2010

• Jordan since 2021

• Libya from 2007- 2018 and re-entry in 2023

• Syria since 2000

• Sudan since 2007

• Kurdistan region since 2012

AMS Sales Monitors are provided in the form of easy-to use proprietary software (PharmView) and are designed to accurately reflect the quantitative sales of pharmaceutical products in the private sector and show ranking of performance by both unit and value (US$ and local currency) in terms of:

Manufacturers, Products, Product form, ATC1-ATC4 Classification, % of Total Market Share, % of the Selected Market Share, Growth and Evolution.

The software application PharmView can provide data in various shapes and forms thus ensuring it

meets our client’s needs. PharmView